Individuals with rheumatoid arthritis or osteoarthritis often experience a recurring pattern. A flare-up causes joint swelling and pain, leading to medication administration. However, tissue damage typically begins before the drug takes effect. This is because inflammation has already progressed.
An implanted material that detects flare-ups at the molecular level and automatically releases anti-inflammatory drugs before severe symptoms develop would represent a significant advancement.
This concept has now been realized. A team of chemists at the University of Cambridge has developed such a material. Their findings were published in the Journal of the American Chemical Society in September 2025. Led by Professor Oren A. Scherman at the Melville Laboratory for Polymer Synthesis, the research demonstrates a smart polymer network. This polymer mechanically responds to pH changes within the physiologically relevant range of the human body and releases its cargo in direct proportion to those changes.
The implications of this technology extend beyond arthritis. The same principle could be applied to cancerous tumors, inflamed tissues, or any anatomical site where pH shifts serve as early indicators of disease.
What Your Body Is Telling You in pH
The body utilizes pH as a form of chemical communication.
In a healthy joint, the local pH is approximately 7.5, which is slightly alkaline and consistent with most healthy tissues. During an arthritic flare-up, the inflammatory process generates acidic byproducts, causing the pH around the cartilage surface to drop as low as 5.5. This decrease is not incidental; it directly reflects underlying biological processes.
A similar pH signal is observed in tumors. Cancer cells metabolize glucose differently from healthy cells, producing lactic acid as a byproduct. Consequently, the environment surrounding a tumor becomes measurably more acidic, typically ranging from pH 6.0 to 6.8, compared to healthy tissue at pH 7.4.
These pH shifts function as the body’s intrinsic distress signals. The Cambridge team investigated whether it is possible to engineer a material that can detect and respond to these chemical cues.
The Molecular Lock: How the Chemistry Works
The central innovation is a concept known as kinetic locking. This principle is fundamental to the material’s function. It involves two molecules fitting together like a hand inside a glove, forming a host-guest complex. The host is a barrel-shaped molecule called cucurbituril, specifically CB[7] and CB[8]. It has a hydrophobic interior that attracts certain guest molecules and traps them inside.
The research team designed a specialized guest molecule, BPI, which features a carboxylic acid group at one end. In a slightly acidic environment (low pH), this group retains a hydrogen atom and remains electrically neutral. Under these conditions, the host molecule CB[7] can freely associate and dissociate with the guest, resulting in a flexible, dynamic, and loosely bound complex.
When the pH rises above a certain threshold and the environment becomes more alkaline, the carboxylic acid group loses its hydrogen atom and becomes negatively charged, forming a carboxylate. This negative charge generates a strong repulsive force with the negatively charged rim of the cucurbituril barrel, preventing dissociation. It effectively locks the complex in place. This lock is exceptionally strong. The team tested it against one of the most competitive binding molecules known in cucurbituril chemistry: pyridinium adamantane, which has a binding affinity of 2 × 10¹² M⁻¹. Even in the presence of this highly competitive molecule, the BPI-cucurbituril complex remained locked at high pH and could not be broken apart.
Crucially, the process is completely reversible. When the pH is lowered by adding acid, the carboxylate regains a hydrogen atom, becomes neutral, the repulsion disappears, and the barrel unlocks. The researchers demonstrated this reversibility over 10 complete lock-unlock cycles, with no degradation in performance.
Building It Into a Material
While this molecular mechanism is notable in a test tube, the Cambridge team significantly extended its application.
The researchers incorporated the BPI guest molecule into a polymer network. This network is a three-dimensional mesh of interconnected chains, resembling a molecular sponge. The cucurbituril molecules act as crosslinks, holding the chains together at specific junction points. Because these crosslinks can lock and unlock depending on pH, the entire material changes its physical properties in response to the chemical environment.
The transformation in material properties is both dramatic and quantifiable:
Stiffness: At acidic pH (pH 3), the material behaves like a soft, elastic hydrogel. It is flexible and easily deformed. Its Young’s modulus (a measure of stiffness) is 4 kPa, which is typical for soft biological tissue. At basic pH (pH 12), the locked crosslinks make the material ten times stiffer, with a Young’s modulus of 40 kPa. The transition between these states is fully reversible.
Compression resistance: Compressing the material to 60% of its original size required seven times more force at high pH (162 kPa) than at low pH (21 kPa). When joints compress during movement, a stiffer, more rigid material resists deformation more effectively.
Stress relaxation: At low pH, the material relaxes stress almost instantly within 10 seconds because crosslinks can detach and reattach freely. At high pH, the locked crosslinks remain intact over a 1,000-second observation window without relaxation. This is the difference between a dynamic, fluid-like material and a static, solid-like one.
Viscoelasticity: The ratio of energy lost to energy stored during deformation, as measured by tan δ, drops from above 0.6 (highly flexible) at low pH to essentially 0.02 (nearly rigid) at high pH. This entire switching process was demonstrated over ten complete cycles, confirming exceptional reversibility.
The Drug Delivery Demonstration
To demonstrate the material’s medical potential, the team loaded the polymer network with a small-molecule dye as a stand-in for a drug, then compressed it cyclically at two pH values representing a healthy joint (pH 7.5) and an arthritic joint (pH 5.5).
The results were striking. At the lower, arthritic pH, the crosslinks are in their unlocked, more dynamic state, the material is softer and more easily compressed. Compression physically squeezes more cargo out of the network. After three hours of cyclic compression, the arthritic-pH condition produced 32% more cargo release than the healthy-pH condition.
No external signal was required. No temperature change, light pulse, or electronic trigger was necessary. The material responded solely to the chemistry of its environment, specifically the drop in pH that occurs naturally during an arthritic flare-up, and released more of its contents as a direct consequence.
The researchers describe this as a self-regulated, autonomous drug delivery system. The joint environment signals the material when to release its contents and in what quantity. The response is both proportional and immediate.
Why This Matters: The Bigger Picture
Current drug delivery approaches for arthritis and cancer face significant limitations. Systemic medications distribute the drug throughout the entire body, even when only one joint or tumor requires treatment. Targeted delivery systems based on nanoparticles or chemically sensitive bonds often exhibit poor reversibility, narrow pH responsiveness, or limited control over release rate.
The Cambridge system addresses all three limitations. It operates across the entire physiologically relevant pH range from 4.5 to 7.5. The material is fully reversible, returning to its original state when pH normalizes, and functions autonomously without any external control system.
The same approach could work for cancer drug delivery. Tumor microenvironments are measurably more acidic than healthy tissue. A polymer implant at a tumor site could respond to that acidity by releasing chemotherapy agents directly where they are needed, reducing systemic side effects.
According to Professor Scherman’s team, this work opens new avenues for smart, autonomous drug delivery, enabling controlled release of anti-inflammatory or immunosuppressive drugs in diseases such as rheumatoid arthritis and other conditions.
The material functions as a responsive machine, interpreting its chemical environment and acting accordingly. Biological signals initiate the response, and the chemical system executes it.